<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02099409</url>
  </required_header>
  <id_info>
    <org_study_id>SPIDLUX 4</org_study_id>
    <nct_id>NCT02099409</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg</brief_title>
  <official_title>Open Label Single Center Randomized Cross Over Study to Validate Current Algorithms and Evaluate Safety and Efficacy of Closed Loop Insulin Delivery (FlorenceD2 System) in Children With Type 1 Diabetes Between 6 - 12 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier du Luxembourg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate current algorithms and evaluate safety and efficacy
      of overnight closed loop insulin delivery (FlorenceD2 system) in children with type 1
      diabetes between 6 - 12 years of age in Luxembourg .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time spent in normal glucose range ( mg/dl)</measure>
    <time_frame>At least 5 hours between 7 pm and 7 am</time_frame>
    <description>Glucose will be measured with a Continuous glucose monitoring device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>glucose variability ( excursions in mg/dl)</measure>
    <time_frame>7 pm - 7 am</time_frame>
    <description>Continuous Glucose Monitoring device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in low glucose range (&lt; 60 mg/dl)</measure>
    <time_frame>7 pm till 7 am</time_frame>
    <description>Continuous Glucose Monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time spent in low glucose range (&lt;70 mg/dl)</measure>
    <time_frame>7 pm till 7 am</time_frame>
    <description>continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time spent in high glucose range (&gt;180mg/dl)</measure>
    <time_frame>7 pm - 7 am</time_frame>
    <description>continuous glucose monitoring</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Starting with FLORENCED2 followed by open loop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Start 2 Overnight periods with closed loop through FLORENCED2 Device , followed by 2 overnight periods with open loop.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Start open loop followed by FLORENCED2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Start with 2 overnight periods with open loop , followed by 2 overnight with closed loop FLORENCED2</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FLORENCED2</intervention_name>
    <description>FLORENCED2 device ensures the closed loop between Freestyle Navigator II and the DANA DIABECARE R</description>
    <arm_group_label>Starting with FLORENCED2 followed by open loop</arm_group_label>
    <arm_group_label>Start open loop followed by FLORENCED2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 6 - ≤12 years

          -  With type 1 diabetes for 6 months or more and

          -  Pump user for at least 6 months.

          -  HbAc1 should be &lt;11 %.

          -  No medication or physical or psychological disease should be present, which could
             interfere with the study.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carine deBeaufort, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier du Luxembourg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roman Hovorka, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gosia Wilinska, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrike Schierloh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier du Luxembourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>DECCP Clinique Pédiatrique de Luxembourg/CHL</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DECCP Pediatric Clinic , CHLuxembourg</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Luxembourg</country>
  </location_countries>
  <link>
    <url>http://www.spidiman.eu</url>
    <description>SPIDLUX 4 is a sub study of the SPIDIMAN project</description>
  </link>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2014</study_first_submitted>
  <study_first_submitted_qc>March 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2014</study_first_posted>
  <last_update_submitted>September 15, 2014</last_update_submitted>
  <last_update_submitted_qc>September 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier du Luxembourg</investigator_affiliation>
    <investigator_full_name>Carine de Beaufort</investigator_full_name>
    <investigator_title>MD , PhD</investigator_title>
  </responsible_party>
  <keyword>Type 1 diabetes mellitus</keyword>
  <keyword>children</keyword>
  <keyword>closed loop</keyword>
  <keyword>cross over</keyword>
  <keyword>overnight</keyword>
  <keyword>FLORENCED2</keyword>
  <keyword>DANA Diabecare R pump</keyword>
  <keyword>FreeStyle Navigator II</keyword>
  <keyword>Dexcom G4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

